{"database": "lobbying", "table": "lobbying_activities", "rows": [[2824101, "1dc81afa-c877-46aa-bd37-07482c0172ad", "Q2", "TWENTY-FIRST CENTURY GROUP, INC.", 38687, "NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)", 2022, "second_quarter", "MED", "Research and treatment related to suicide prevention for veterans and patients with bipolar depression.", "HOUSE OF REPRESENTATIVES,SENATE", 24000, null, 0, 0, "2022-07-18T12:59:07-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2824101"], "units": {}, "query_ms": 5.122778005897999, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}